A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING EFFICACY, SAFETY, AND PHARMACOKINETICS OF CROVALIMAB IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)
- Registry ID
- BO46107
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- HOFFMANN-LA ROCHE LIMITED
- Last update
- 2025-12-04
Conditions
- ANTIPHOSPHOLIPID SYNDROME
View on source registry